Company · CIK 1998311
APRINOIA Therapeutics Inc.
| CIK | 1998311 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-276696 | 2024-01-26 | 2024-10-28 | 7 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-10-28 | RWWithdrawn | 333-276696 | 0001140361-24-044368 |
| 2024-09-30 | EFFECTDeclared effective | 333-276696 | 9999999995-24-003013 |
| 2024-09-11 | F-1/AAmendment | 333-276696 | 0001140361-24-040849 |
| 2024-08-28 | F-1/AAmendment | 333-276696 | 0001140361-24-038892 |
| 2024-05-17 | F-1/AAmendment | 333-276696 | 0001140361-24-026740 |
| 2024-02-26 | F-1/AAmendment | 333-276696 | 0001140361-24-009416 |
| 2024-01-26 | F-1Registration filed | 333-276696 | 0001140361-24-003920 |
| 2023-11-13 | DRSDraft made public | 377-06948 | 0001140361-23-052538 |